These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 24176494)
21. Effect of atorvastatin on humoral immune response to 23-valent pneumococcal polysaccharide vaccination in healthy volunteers: The StatVax randomized clinical trial. Wildes TJ; Grippin A; Fasanya H; Dyson KA; Brantly M Vaccine; 2019 Feb; 37(10):1313-1324. PubMed ID: 30686636 [TBL] [Abstract][Full Text] [Related]
22. A bivalent pneumococcal histidine triad protein D-choline-binding protein A vaccine elicits functional antibodies that passively protect mice from Streptococcus pneumoniae challenge. Ochs MM; Williams K; Sheung A; Lheritier P; Visan L; Rouleau N; Proust E; de Montfort A; Tang M; Mari K; Hopfer R; Gallichan S; Brookes RH Hum Vaccin Immunother; 2016 Nov; 12(11):2946-2952. PubMed ID: 27392182 [TBL] [Abstract][Full Text] [Related]
23. Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial. Madhi SA; Cutland CL; Jose L; Koen A; Govender N; Wittke F; Olugbosi M; Meulen AS; Baker S; Dull PM; Narasimhan V; Slobod K Lancet Infect Dis; 2016 Aug; 16(8):923-34. PubMed ID: 27139805 [TBL] [Abstract][Full Text] [Related]
24. Compound 48/80 acts as a potent mucosal adjuvant for vaccination against Streptococcus pneumoniae infection in young mice. Zeng L; Liu Y; Wang H; Liao P; Song Z; Gao S; Wu Y; Zhang X; Yin Y; Xu W Vaccine; 2015 Feb; 33(8):1008-16. PubMed ID: 25595867 [TBL] [Abstract][Full Text] [Related]
25. Th17/Th1 biased immunity to the pneumococcal proteins PcsB, StkP and PsaA in adults of different age. Schmid P; Selak S; Keller M; Luhan B; Magyarics Z; Seidel S; Schlick P; Reinisch C; Lingnau K; Nagy E; Grubeck-Loebenstein B Vaccine; 2011 May; 29(23):3982-9. PubMed ID: 21481328 [TBL] [Abstract][Full Text] [Related]
26. Synchrony in serum antibody response to conserved proteins of Streptococcus pneumoniae in young children. Ren D; Almudevar AL; Pichichero ME Hum Vaccin Immunother; 2015; 11(2):489-97. PubMed ID: 25692218 [TBL] [Abstract][Full Text] [Related]
27. A Phase 1 Randomized, Placebo-controlled, Observer-blinded Trial to Evaluate the Safety and Immunogenicity of Inactivated Streptococcus pneumoniae Whole-cell Vaccine in Adults. Keech CA; Morrison R; Anderson P; Tate A; Flores J; Goldblatt D; Briles D; Hural J; Malley R; Alderson MR Pediatr Infect Dis J; 2020 Apr; 39(4):345-351. PubMed ID: 31895881 [TBL] [Abstract][Full Text] [Related]
28. Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial. Wressnigg N; Pöllabauer EM; Aichinger G; Portsmouth D; Löw-Baselli A; Fritsch S; Livey I; Crowe BA; Schwendinger M; Brühl P; Pilz A; Dvorak T; Singer J; Firth C; Luft B; Schmitt B; Zeitlinger M; Müller M; Kollaritsch H; Paulke-Korinek M; Esen M; Kremsner PG; Ehrlich HJ; Barrett PN Lancet Infect Dis; 2013 Aug; 13(8):680-9. PubMed ID: 23665341 [TBL] [Abstract][Full Text] [Related]
29. Effects of varying antigens and adjuvant systems on the immunogenicity and safety of investigational tetravalent human oncogenic papillomavirus vaccines: results from two randomized trials. Van Damme P; Leroux-Roels G; Simon P; Foidart JM; Donders G; Hoppenbrouwers K; Levin M; Tibaldi F; Poncelet S; Moris P; Dessy F; Giannini SL; Descamps D; Dubin G Vaccine; 2014 Jun; 32(29):3694-705. PubMed ID: 24674663 [TBL] [Abstract][Full Text] [Related]
30. Antibodies to PcpA and PhtD protect mice against Streptococcus pneumoniae by a macrophage- and complement-dependent mechanism. Visan L; Rouleau N; Proust E; Peyrot L; Donadieu A; Ochs M Hum Vaccin Immunother; 2018 Feb; 14(2):489-494. PubMed ID: 29135332 [TBL] [Abstract][Full Text] [Related]
31. Phase I, randomized, observer-blind, placebo-controlled studies to evaluate the safety, reactogenicity and immunogenicity of an investigational non-typeable Haemophilus influenzae (NTHi) protein vaccine in adults. Leroux-Roels G; Van Damme P; Haazen W; Shakib S; Caubet M; Aris E; Devaster JM; Peeters M Vaccine; 2016 Jun; 34(27):3156-3163. PubMed ID: 27133877 [TBL] [Abstract][Full Text] [Related]
32. Formulation, stability and immunogenicity of a trivalent pneumococcal protein vaccine formulated with aluminum salt adjuvants. Ljutic B; Ochs M; Messham B; Ming M; Dookie A; Harper K; Ausar SF Vaccine; 2012 Apr; 30(19):2981-8. PubMed ID: 22381074 [TBL] [Abstract][Full Text] [Related]
33. Safety and immunogenicity of a novel multiple antigen pneumococcal vaccine in adults: A Phase 1 randomised clinical trial. Entwisle C; Hill S; Pang Y; Joachim M; McIlgorm A; Colaco C; Goldblatt D; De Gorguette D'Argoeuves P; Bailey C Vaccine; 2017 Dec; 35(51):7181-7186. PubMed ID: 29132988 [TBL] [Abstract][Full Text] [Related]
34. Induction of immunologic memory following primary vaccination with the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine in infants. Knuf M; Pankow-Culot H; Grunert D; Rapp M; Panzer F; Köllges R; Fanic A; Habib A; Borys D; Dieussaert I; Schuerman L Pediatr Infect Dis J; 2012 Jan; 31(1):e31-6. PubMed ID: 21909049 [TBL] [Abstract][Full Text] [Related]